Inquilinus limosus isolated from a patient with chronic cystic fibrosis. First report in Mexico and evidence that co-infection with Pseudomonas aeruginosa promotes the accelerated and increased formation of extracellular neutrophil traps

Indian J Med Microbiol. 2022 Jan-Mar;40(1):156-159. doi: 10.1016/j.ijmmb.2021.11.010. Epub 2021 Dec 2.

Abstract

Cystic fibrosis is characterized by abnormal mucous secretions in the lungs that favor the proliferation of colonizing bacteria, with Pseudomonas aeruginosa and Staphylococcus aureus being the most isolated, however, other less known species could also have an impact on the health of the patient. Here we demonstrate the isolation and antibiotic resistance profiles of Inquilinus limosus, a rarely reported multidrug resistant bacterium, and compare them to a co-infectant strain of Pseudomonas aeruginosa. Likewise, we found that co-infection with both bacteria promotes increased formation of neutrophil extracellular traps, which can have an impact on the disease severity and make treatment difficult.

Keywords: Cystic fibrosis; Inquilinus limosus co-infection; Neutrophil extracellular traps.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Coinfection* / drug therapy
  • Cystic Fibrosis* / complications
  • Extracellular Traps*
  • Humans
  • Mexico
  • Neutrophils
  • Pseudomonas Infections* / drug therapy
  • Pseudomonas aeruginosa
  • Rhodospirillaceae

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • Inquilinus limosus